e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Recent advances in the treatment and pathogenesis of pulmonary diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Angiopoietin-1 variant, COMP-Ang1 attenuates hydrogen peroxide-induced acute lung injury
S. R. Kim, Y. H. Choe, K. S. Lee, S. J. Park, K. Y. Lee, H. Moon, H. B. Lee, Y. C. Lee (Jeonju, Republic Of Korea)
Source:
Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Session:
Recent advances in the treatment and pathogenesis of pulmonary diseases
Session type:
E-Communication Session
Number:
4269
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. R. Kim, Y. H. Choe, K. S. Lee, S. J. Park, K. Y. Lee, H. Moon, H. B. Lee, Y. C. Lee (Jeonju, Republic Of Korea). Angiopoietin-1 variant, COMP-Ang1 attenuates hydrogen peroxide-induced acute lung injury. Eur Respir J 2008; 32: Suppl. 52, 4269
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Endothelial- but not leukocytic-NOX2 mediates vascular injury in ischemia/reperfusion syndrome of the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 822s
Year: 2006
Kallistatin protects against LPS-induced mouse lung injury
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Enhanced expression of Robo4 ameliorates LPS-induced acute lung injury in mice
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment
Source: Eur Respir J 2012; 40: 416-423
Year: 2012
Effects of curcumin or dexamethasone on lung ischaemia-reperfusion injury in rats
Source: Eur Respir J 2009; 33: 398-404
Year: 2009
Role of eNOS in ischemia/reperfusion-induced lung injury
Source: Eur Respir J 2007; 30: Suppl. 51, 293s
Year: 2007
Ghrelin attenuates lipopolysaccharide-induced acute lung injury
Source: Eur Respir J 2005; 26: Suppl. 49, 731s
Year: 2005
Intermedin stabilized endothelial barrier function and attenuated ventilator-induced lung injury in mice
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Effect of curcumin on LPS-induced neutrophil activation and acute lung injury
Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation
Year: 2012
N
-acetyl-L-cysteine reduces the increased vascular permeability and VEGF levels in lungs treated with hydrogen peroxide
Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel
in vitro
assays and results from animal models
Year: 2007
Effects of N-acetylcysteine in lipopolysaccharide-induced acute lung injury in the rat: Treatment after acute lung injury
Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances
Year: 2011
Effect of protein S on lipopolysaccharide-induced acute lung injury
Source: Eur Respir J 2006; 28: Suppl. 50, 398s
Year: 2006
PKA- and Epac/Rap-dependent mechanisms of lung endothelial barrier protection in acute lung injury
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009
Eugenol prevents inflammation but not oxidative stress in diesel-induced acute lung injury
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Effect of phosphodiesterase-4 inhibitor on the inflammation, oxidative damage and apoptosis in a saline lavage-induced model of acute lung injury
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018
Amifostine reduces lung vascular permeability via suppression of inflammatory signalling
Source: Eur Respir J 2009; 33: 612-624
Year: 2009
Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury
Source: Eur Respir J 2013; 41: 165-176
Year: 2013
Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017
SIRT1 contributes to LPS-induced lung injury through interaction with mitochondrial ROS generation
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept